Bioactivity:

Pivanex is a derivative of Butyric acid and is an orally active HDAC inhibitor. Pivanex has antimetastic and antiangiogenic properties. Pivanex down-regulates bcr-abl protein and increases apoptosis.

CAS nr:

122110-53-6

Purity:

98%

Molecular Weight:

202,25

SMILES:

CCCC(OCOC(C(C)(C)C)=O)=O

Formula:

C10H18O4

Pathway:

DNA Damage/DNA Repair,Chromatin/Epigenetic,Apoptosis,Angiogenesis,Tyrosine Kinase/Adaptors,Cytoskeletal Signaling

Target:

HDAC,HDAC,Apoptosis,Bcr-Abl,Bcr-Abl,Bcr-Abl